Loading...

TATVA Tatva Chintan Pharma Chem Ltd Litigation, disputes or regulatory action Announcement

Ttv

TTV

Tatva Chintan Pharma Chem Ltd

(TATVA)

2025 Announcement

Analyst / Institutional Inv...

Analyst / Institutional Mee...

One-on-One Meeting

Investor Meeting Scheduled

Investor Meeting Notice

Investor Meeting

Investor Meeting

Investor Meeting

Earnings Call Summary

Newspaper Publication

Earnings Call Recording

Investor Presentation

Management Authorization

Management Change

Board Meeting Outcome

Financial Results

Price Movement Clarified

Earnings Call Scheduled

Board Meeting Notice

Compliance Certificate

Investor Meeting

Investor Meeting

Investor Meeting

Annual Meeting Notice

100 Days Campaign

AGM Announcement

Investor Meeting Scheduled

Dividend Announcement

Investor Meeting Scheduled

Earnings Call Transcript

Financial Results Release

Earnings Call Recording

Investor Presentation

CFO Resignation

Directorate Changes

Earnings Call Scheduled

Compliance Certificate

Credit Rating Downgrade

Price Movement Clarification

Volume Increase Clarification

Annual Compliance Report

Earnings Call Transcript

Earnings Call Recording

Investor Presentation

Export Order Received

Financial Results News

Auditor Appointments

Earnings Call Rescheduled

Earnings Call Scheduled

Contact Details Update

Compliance Certificate

Investor Meeting

Investor Meeting Scheduled

Earnings Call Transcript

Financial Results Published

Earnings Call Recording

Investor Presentation

Earnings Call Scheduled

Compliance Certificate

Registrar Name Change

Investor Meeting Announced

Credit Rating Change

Earnings Update

Financial Results Published

Earnings Call Recording

Financial Results Update

Earnings Call Scheduled

Closure Revoked

Compliance Certificate

Share Volume Spike

Investor Meeting Scheduled

Regulatory Order

Investor Meeting Scheduled

AGM Announcement

AGM Announcement

AGM Announcement

Dividend Taxation Update

Investor Meeting Schedule

Earnings Call Transcript

Financial Results Publication

Earnings Call Recording

Investor Presentation

Earnings Call Schedule

Compliance Certificate

Investor Meeting Intimation

Investor Meeting

Compliance Report Submission

Earnings Call Transcript

Financial Results Published

Earnings Call Recording

Monitoring Agency Report

IPO Fund Utilization

Investor Presentation

Environmental Clearance

Earnings Call Schedule

Compliance Certificate Subm...

Certificate Submission

Compliance Certificate Subm...

Investor Meeting

Investor Meeting

Investor Meeting Intimation

Investor Meetings

Investor Meeting

Investor Meeting Schedule

Earnings Call Transcript

Monitoring Agency Report

Monitoring Agency Report Su...

Deviation in Fund Utilization

Utilization of IPO Funds

Financial Results Published

Earnings Call Recording

Investor Presentation

Earnings Call Scheduled

Compliance Certificate Subm...

Investor Meeting

Maintenance Shutdown

Report Submission

Earnings Call Transcript

Submission of Monitoring Ag...

Statement of Deviation/Vari...

Statement of Deviation

Newspaper Publication

Earnings Call Recording

Investor Presentation

Earnings Call Scheduled

Compliance Certificate Subm...

Credit Rating Reaffirmed

Insider Trading Report

Equity shares sale

Equity Shares Sold

Equity Share Sale

Equity Shares Sold

Equity Sale for Public Shar...

Qualified Institutional Pla...

Fund Raising Committee Meeting

Fund Raising Committee

Investor Meetings

Dividend Taxation

Financial Statements

Secondary Offerings

Investor Meetings

Financial Statements

Earnings Guidance

Financial Statements

Investor Meetings

New Product Launches

Investor Meetings

One-on-One Virtual meeting

Analyst/Investor Meet

Financial Updates

Monitoring Agency Report Su...

Rights Offerings

Publication of Financial Re...

Earnings Call Recording

Disclosure of Related Party...

Financial Statements

Financial Statement Release

External Links:

Data:

Tatva Chintan Pharma Chem Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ending December 31, 2024, confirming the status of securities dematerialization.

AI Assistant

Tatva Chintan Pharma Chem Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.